Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study - van der Heijde, D; Tanaka, Y; Fleischmann, R (Arthritis Rheum, 2013)
et al.